Related references
Note: Only part of the references are listed.Computational Analysis of Breast Cancer GWAS Loci Identifies the Putative Deleterious Effect of STXBP4 and ZNF404 Gene Variants
Tariq Ahmad Masoodi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Ki-67 as a prognostic marker according to breast cancer molecular subtype
Nahed A. Soliman et al.
CANCER BIOLOGY & MEDICINE (2016)
Survivin: A molecular biomarker in cancer
Praveen Kumar Jaiswal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
Association between functional variants in BIRC5/survivin gene 3′ untranslated region and mRNA expression in lymphoblastoid cell lines
Feifei Pu et al.
ONCOLOGY LETTERS (2015)
Survinin expression in patients with breast cancer during chemotherapy
S. R. Marsicano et al.
TUMOR BIOLOGY (2015)
Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
Ying-Chun Zhao et al.
MOLECULAR MEDICINE REPORTS (2014)
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
Chunsen Xu et al.
BREAST CANCER (2014)
Survivin expression in breast lobular carcinoma: Correlations with normal breast tissue and clinicomorphological parameters
Marian Adamkov et al.
ACTA HISTOCHEMICA (2013)
Inherited Genetic Susceptibility to Breast Cancer The Beginning of the End or the End of the Beginning?
Maya Ghoussaini et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Predictive Role of Tumor Size in Breast Cancer with Axillary Lymph Node Involvement - Can Size of Primary Tumor be used to Omit an Unnecessary Axillary Lymph Node Dissection?
Elahe Orang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Treat cancers by targeting survivin: Just a dream or future reality?
Mohane Selvaraj Coumar et al.
CANCER TREATMENT REVIEWS (2013)
Association between survivin gene promoter-31G/C and-644C/T polymorphisms and non-small cell lung cancer
E. Aynaci et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Differential expression of testin and survivin in breast cancer subtypes
Manuela Sarti et al.
ONCOLOGY REPORTS (2013)
Survivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer
Qi Lin et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Survivin T9809C, an SNP Located in 3′-UTR, Displays a Correlation with the Risk and Clinicopathological Development of Hepatocellular Carcinoma
Yih-Shou Hsieh et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer
Hong Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study
Xiao Ou Shu et al.
CANCER RESEARCH (2012)
Size surprise? Tumour size, nodal status, and outcome after breast cancer
W. D. Foulkes
CURRENT ONCOLOGY (2012)
Association between survivin-31G>C promoter polymorphism and cancer risk: a meta-analysis
Xiefeng Wang et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis
Chunguang Li et al.
PLOS ONE (2012)
Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma
M. Adamkov et al.
NEOPLASMA (2012)
Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph
Delphine Casabonne et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility
Naoko Kawata et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients
Julija Hmeljak et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Prognostic Significance of Survivin Polymorphisms on Non-small Cell Lung Cancer Survival
Juncheng Dai et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Survivin: a promising biomarker in breast carcinoma
M. Adamkov et al.
NEOPLASMA (2010)
The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism
R. Boidot et al.
ONCOGENE (2010)
Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma
Xiaoya Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation
Edgar Wingender
BRIEFINGS IN BIOINFORMATICS (2008)
New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia
Mirela Levacic Cvok et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas
Romain Boidot et al.
GENES CHROMOSOMES & CANCER (2008)
Polymorphisms in the survivin gene and the risk of lung cancer
Jin Sung Jang et al.
LUNG CANCER (2008)
Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions
Lilach Kleinberg et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
N Barnes et al.
BRITISH JOURNAL OF CANCER (2006)
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
YY Shi et al.
CELL RESEARCH (2005)
Survivin is an independent prognostic marker for risk stratification of breast cancer patients
PN Span et al.
CLINICAL CHEMISTRY (2004)
Prognostic importance of survivin in breast cancer
SM Kennedy et al.
BRITISH JOURNAL OF CANCER (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Share Paper
